Loading

Journal of Addiction Medicine and Therapy

Co-occurring Addiction of Synthetic Benzodiazepine Clonazolam and Propylhexedrine presenting as Acute Brief Psychosis

Case Report | Open Access

  • 1. Department of Family Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, USA
+ Show More - Show Less
Corresponding Authors
Muhammad A. Ghazi, Department of Family Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 462 Grider Street, Buffalo, NY, USA, Tel: 716-831-8612
Abstract

We report the case of a 25-year-old man who developed acute neuropsychiatric sequelae after consuming a designer benzodiazepine (Clonazalam) with concurrent ingestion of over-the-counter (OTC) nasal decongestant Benzedrex (Propylhexedrine). The psychiatric and medical symptoms of extreme aggression, paranoia, visual hallucinations, and anterograde amnesia subsided within 24 hours of admission. The report highlights the fact that synthetic and OTC drugs abuse, including amphetamine-type stimulants and new psychoactive substances are drastically increasing. Moreover, with the growing number of new products, which are freely available on the internet, it is likely that drug users will innovate with unique formulations and experiment with combination of old and new drugs of abuse. Hence, the medical personnel should be educated and mindful of uncommon cases of co-occurring multiple drug use and be alert for unexpected responses to therapeutic interventions and to a rapid change in patient presentation.

Citation

Ghazi MA, Mohmand M (2017) Co-occurring Addiction of Synthetic Benzodiazepine Clonazolam and Propylhexedrine presenting as Acute Brief Psychosis. J Addict Med Ther 5(2): 1037.

Keywords

•    Designer benzodiazepine
•    Clonazolam
•    Propylhexedrine
•    Benzedrex

ABBREVIATIONS

OTC: Over-the-counter; ED: Emergency Department; LSD: Lysergic Acid Diethylamide

INTRODUCTION

Drug use is a growing national issue, compounded with an ominous new trend of increased recreational use of new psychoactive substance - synthetic or designer benzodiazepines. In the last few years, the number of designer substances with potentially harmful effects have increased drastically and become readily available through over the counter (OTC) and online vendors [1,2]. Today more than 50 different synthetic benzodiazepine are available on the illegal internet market, with some of the first designer benzodiazepines being diclazepam, flubromazepam and pyrazolam, and more recently clonazolam, deschloroetizolam, flubromazolam, nifoxipam and cinazepam [3]. Such availability enhances risk of complications like over-doses and psychosis as a result of intoxication. These new designer benzodiazepines drugs have the classic benzodiazepine properties that are attractive to the recreational drug abusers-they are sedative, hypnotic, anxiolytic, and muscle relaxant. Despite similarities in structure to prescription benzodiazepines, none have been tested for safety or efficacy in humans and are not regulated by law and lack oversight in their manufacturing processes [4]. Clonazolam has a fast onset of action of 20-60 minutes with duration of 8-14 hours. Its capsule, tablet, pellet, blotter and powder form is now widely available online, and is advertised under the brand name Clonazolam or Clonitrazolam. It is reputed to be highly potent, and concerns have been raised that Clonazolam may pose moderately higher risks than other synthetic benzodiazepines due to their ability to produce strong sedation and amnesia at oral doses of 0.5 mg [2].

In this report, we focus on the concurrent use of nasal decongestant Propylhexedrine (Benzedrex) with Clonazolam. In contrast to the new designer drugs, Propylhexedrine use disorder is documented in several case reports since 1970 mentioning negative effects of abuse, including pulmonary hypertension, myocardial infarction, psychosis, ventricular arrhythmias, shock and death. The OTC nasal decongestant Propylhexedrine is a strong alpha-adrenergic sympatho-mimetic that delivers 0.4-0.5 mg of the drug in each 800 mL of air and was made as a substitute for the widely abused amphetamine sulfate (Benzedrine) inhaler, which is no longer in the market. This drug is considered a “last resort” to stimulant users when they are unable to acquire amphetamine or other controlled stimulants. Users disassemble the inhaler and extract the cotton plug from the inhaler which is saturated with 250mg of propylhexedrine. The cotton plug is either swallowed or soaked in water to make a solution for intravenous injection or ingested orally [5].

CASE PRESENTATION

A 25-year-old man with a history of polysubstance use disorder and on prescribed medications (Baclofen, Bisoprolol Fumarate, Nortriptyline, Amlodipine) presented to the Emergency Department (ED) after his mother recognized his aggressive and odd behavior. Upon first responder arrival, he was noted to be confused and aggressive. On arrival to the ED, blood pressure was 160/95 mmHg, pulse rate 106 beats/min, respiratory rate 19 breaths/min, temperature 98.6 C, and oxygen saturation 97%. Physical examination was notable for equally round and reactive mid-range pupils. He was severely agitated, anxious, and reported of visual hallucinations and anterograde amnesia. He was assessed by the Psychiatrist and admitted to the medical inpatient unit for stabilization.

Initial laboratory studies (complete blood count, comprehensive metabolic panel and lactate levels) drawn within minutes of ED arrival were within normal limits. Electrocardiogram demonstrated sinus tachycardia with a rate of 106 beats/min, with normal axis and conduction. Urine drug screening performed by immunoassay was positive for benzodiazepines and cannabinoids and negative for amphetamines, barbiturates, cocaine, opiates, and opioids. Serum ethanol, acetaminophen, and salicylate concentrations were undetectable.

The patient developed increasing agitation and aggressive behavior during his hospital stay, beginning on hospital day two, as he physically assaulted the staff. Acute agitation and psychotic symptoms were controlled with Lorazepam and Haloperidol respectively. Symptoms and his mental status improved significantly over the course of the day as medications were titrated and weaned. A Psychiatric evaluation revealed a significant history of anxiety disorder with an eight-year history of polysubstance use comprising of Hydrocodone, OxyContin, Lysergic acid diethylamide (LSD), Cocaine, Opiates, Amphetamines, Benzodiazepines, Marijuana, Nicotine and Pregablin. He denied use of phencyclidine PCP, bath salts, opiates, alcohol and cocaine within the previous month. The patient denied any suicidal ideations, but did experience significant visual hallucinations, anterograde amnesia, and paranoia. He reported ingesting 100 mg of Internet-bought Clonazolam over the course of two days in the prior week. In addition, he used 2 to 4 Benzedrex inhaler cottons (500 to 1000 mg) daily within the same week. After completing the detoxification with benzodiazepines, he was discharged to outpatient substance use counselling program.

DISCUSSION

According to recent reviews, benzodiazepines are the second most commonly used class of medications, after opioids [6]. The high availability and low prices of the alternative designer benzodiazepines through online vendors makes it easy for patients to self-medicate and develop addiction disorder. These new unscreened and unregulated designer benzodiazepines like Clonazolam are also concurrently taken with stimulants to decrease unpleasant effects, which can alter the clinical symptoms at presentation [4]. In this case, the patient ingested OTC Propylhexedrine — an old stimulant drug of last resort to abusers which has been on the market for decades. The unrestricted access to these new drug alternatives in multidrug users entails the risk of toxicity and death for users of designer benzodiazepines. As the number of drug overdose deaths continues to increase, novel drugs such as designer benzodiazipines, including Clonazolam, should be suspected as an offending agent, especially given its gaining popularity in the United States.

Our patient had purchased the Clonazolam over the internet in tablets of 0.5 mgs, and reported that he ingested 100 mg in an attempt to control his anxiety. Previous literature cases of Clonazolam toxicity or withdrawal are not published, and as such limited information on the acute toxicity, withdrawal and drug interaction are reported. In one study, new designer benzodiazepines metabolites were detected in 77 cases of which 7 were Clonazolam [3]. Through cross-reactivity, synthetic benzodiazepines may be detected in urine by commercial immunochemical tests with a concentration greater than 140 ng/mL [8]. In the case of our patient, routine drug screen and benzodiazepine screening panel in the emergency department, yielded a positive result for benzodiazepines. This case is limited by the inability to document levels of Clonazolam in our patient. Moreover, the mass spectrometric tests utilized for conformation did not analyze for all metabolites of the designer benzodiazepines. Additionally, other drugs were detected in our patient, thus making it difficult to assess the clinical effects of Clonazolam alone. The patient in study was observed to display progressive neuropsychiatric symptoms complicated with aggression and visual hallucinations that waxed and waned during his treatment, which could have been consistent with a benzodiazepine withdrawal, to a manifestation of pharmacodynamics interaction with Propylhexedrine, or to substance-induced delirium. Designer drugs, including Clonazolam, should be investigated in patients with a history of substance abuse presenting with a clinical progression of acute onset of neuropsychiatric symptoms. The acute onset of hallucinations and cognitive impairment in young healthy individuals without a history of psychotic disorder should alert the clinician to take detailed history of designer drugs of abuse.

We conclude that the radical online availability of designer Benzodiazepines and OTC drugs like Propylhexedrine, make it imperative for the providers to take history of the internet buying of drugs in all suspected cases. Given the emerging problem of new designer benzodiazepines, clinicians should be educated on the assessment and therapeutic intervention protocols. Individuals with designer drug toxicity and withdrawal, inclusive of Clonazolam, should be admitted for clinical assessment of hemodynamic instability and improvement of their altered mental status [9].

Ghazi MA, Mohmand M (2017) Co-occurring Addiction of Synthetic Benzodiazepine Clonazolam and Propylhexedrine presenting as Acute Brief Psychosis. J Addict Med Ther 5(2): 1037.

Received : 16 Dec 2017
Accepted : 17 Dec 2017
Published : 29 Dec 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X